12.00 EGP

adolor ampoules contain ketorolac tromethamine 30 mg/2 ml .

ADOLOR 30MG AMP; ketorolac, anti inflammatory agents .


adolor ampoules contain ketorolac tromethamine 30 mg/2 ml .


adolor ampoules is indicated for the the short-term management of moderate to severe acute post-operative pain . Treatment should only be initiated in hospitals . The maximum duration of treatment is two days .


Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

adolor ampoules is for administeration by intrmuscular or intravenous injection . Intravenous doses should be given over no less than 15 seconds . Adolor ampoules : should not be used for eposural or spinal administration . The time to onset of analgesic effect following both iv and im administration is similar is approximately 30 minutes , with maximum analgesia occurring within one to two hours . the median duration of analgesia is generally four to six hours . dosage should be adjusted according to the severity of the pain and the patient response . the administration of continuous multiple daily doses of ketorolac intramuscularty or intravenously should not should not exceed two days because adverse events may increase with prolonged usage . there has been limited experience with dosing for longer since the vast majority of patients have transferred to oral medication or no longer require analgesic therapy after this time . undesirable effects may be minimized by using the lowest duration necessary to control symptoms . adults : the recommended initial dose of adolor is 15 mg , followed by a dose up to 30 mg every four to six hours as required . in the initial post-operative period , adolor ampoules may be given as often as every , a total daily dose of 90 mg for non -elderly and 60 mg for the elderly , renally -impaired patients and patients less than 50 kg should be exceeded . the maximum duration of treatment should not exceed two days . reduce dosage in patients under 50 kg . opioid analgesics (e.g. morphine , pethidine ) may be used concomitantly , and may be required for optimal analgesic effect in the elderly post -operative period when pain is most severe . ketorolac does not exacerbate opioid-related respiratory depression or sedation . when used in association with adolor im/iv , the daily dose of opioid is usually less than that normally required . however , opioid side-effects should still be considered , espicially in day -case surgery . for patients receving parenteral adolor , and who are converted to ketorolactromethamine oral tablets , the total combined daily dose should not exceed 90 mg ( 60 mg for the elderly , renally – impaired patients less than 50 kg ) and the oral component should not exceed 40 mg on the day the change of formulation is made . patients should be converted to oral treatment as soon as possible. elderly : the elderly are at increased risk of the serious consequences of adverse reactions . if an NSAID is considered necessary , the lowest effective dose should be used and the shortest possible duration . the patients should be monitored regularly for GI bleeding during NSAID therapy . a total daily dose of 60 mg should not be exceeded . children : safety and efficacy in children have not been established . therefore , adolor is not recommended for use in children 16 years of age . renal impairment : contra-indicated in moderate to severe renal impairment , reduce dosage in lesser impairment ( not exceeding 60 mg/day iv or im ) .


symptoms and sings : single ketorolac have been variously associated with abdominal pain , nausea , vomiting , hyperventilation , peptic ulcers and/or erosive gastritis and renal dysfunction which have resolved after discontinuation of dosing


pregnancy , nursing mothers & pediateric use . Do not administer injections preserved with benzyl alcohol to neonates , infants , pregnant women or nursing mothers . Benzyl alcohol has been associated with serious events & death , particularly in pediatric patients . injections preservative free should be used in these populations . ketorolac is xontraindicated in patients with previously demonstrated hypersensitivity in whom aspirin or other prostaglandin synthesis inhibitors induce allergic reactions ( severe anaphylactic -like reactions have been observed ( in such patients) . such reactions have included have included asthma , rhinitis , angioedema , or urticaria . ketorolac is also contraindicated – those with with a history of asthma – children under 16 years of age . ketorolac is contraindicated in patients with history of gastrointestinal bleeding of perfortion , related to previous NSAIDs therapy , active or history of recurrent peptic ulcer / haemorrhage ( two or more distinct episodes of proven ulceration or bleeding ) as with other NSAIDS , ketorolac is contraindicated in patients with severe heart failure , hepatic failure and renal failure . ketorolac is contraindicated in patients with moderate or severe renal impairment (serum creatinine > 160 µmol /l ) or in patients at risk for renal failure due to volume depletion or dehydration . ketorolac is contraindicated in pregnancy , labour , delivery or lactation . ketorolac is contraindicated as prophylactic anagesia before surgery due to inhibition of aggregation and is contraindicated intra-operatively because of the increased risk of bleeding .


store at temperature not exceeding 30 C , away from light . Keep of the reach of children .
carton box containing 3 brown glass ampoules , 2 ml each (30 mg/2 ml) .
PHARCO B International for Pharco Pharmaceuticals .



How to use


There are no reviews yet.

Show reviews in all languages (1)

Be the first to review “ADOLOR 30MG AMP”

Your email address will not be published. Required fields are marked *

Shopping Cart
Don`t copy text!
Scroll to Top
Open chat